深圳高速公路股份(00548.HK):交易商協會接受公司30億元超短期融資券註冊
格隆匯2月13日丨深圳高速公路股份(00548.HK)公吿,公司於一般授權授出後已向中國銀行間市場交易商協會申請註冊發行超短期融資券,並於近日收到交易商協會簽發的《接受註冊通知書》(中市協注[2025]SCP26號)。根據中市協注[2025]SCP26號通知書,交易商協會決定接受公司的超短期融資券註冊,註冊金額為人民幣30億元,註冊額度自《接受註冊通知書》落款日起2年內有效,由中信銀行股份有限公司、招商銀行股份有限公司、興業銀行股份有限公司、寧波銀行股份有限公司和中國光大銀行股份有限公司聯席主承銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.